100 Questions and Answers about Peripheral Artery Disease

.

Emile R. Mohler III, MD is director of the Vascular Medicine program at the University of Pennsylvania Health System and is Associate Professor of Medicine at the University of Pennsylvania.Dr. Mohler received his undergraduate degree from Boston College and attended medical school at Georgetown University Medical School. He completed a medical residency at Georgetown University Medical Center and a fellowship I Cardiovascular disease at Indiana University. Dr. Mohler is board certified in both cardiovascular disease and vascular medicine. He has been teaching and mentoring medical students for more than 20 years.Currently a member of the Cardiovascular Institute, the Institute for Human Gene Therapy and the Institute for Medicine and Engineering at the University of Pennsylvania School of Medicine, Dr Mohler is also an active member several academic and scientific committees. He is a fellow of the American College of Cardiology, the Society for Vascular Medicine, the American Heart Association, and the American College of Physicians. He has lectured extensively, both nationally and internationally, about a wide range of topics related to his clinical and research interests, including diagnosis and management of peripheral artery disease, vascular imaging, the management of cardiovascular risk factors, vascular calcification, various types of coronary heart disease, and the most current treatments for heart disease. The current focus of his research team is the impact of diabetes on adult stem cells and cell therapy for cardiovascular disease.Dr Mohler has published over 130 manuscripts and is an editor of four books. He is an ad hoc reviewer for 9 prestigious peer-reviewed journals; edits the vascular medicine section of UpToDate, and serves on the editorial boards for Arteriosclerosis, Thrombosis and Vascular medicine (ATVB), Endovascular Today and Thrombosis Research and Vascular Medicine. He has been awarded multiple government and industry grants and holds a patent for a noninvasive device that measures limb oxygenation and blood flow.

Alan T. Hirsch, M.D. is Professor of Epidemiology and Community Health at the University of Minnesota School of Public Health in Minneapolis, Minnesota.' He has always maintained a dual focus on individual vascular health and community vascular health.'Dr. Hirsch received his undergraduate degree from Harvard College and attended medical school at the University of California in San Francisco. He completed his internship and residency in the department of medicine at the University of Chicago Hospitals and at the University of California Hospitals in San Francisco. Dr. Hirsch also completed a cardiovascular pharmacology research fellowship at the Cardiovascular Research Institute and Clinical Pharmacology Section, University of California in San Francisco; and a physiology fellowship at the Department of Physiology and Molecular Biology, Harvard Medical School.Dr. Hirsch’s research interests include the evaluation of new medications and new methods to treat peripheral arterial disease.' He also evaluates community-based peripheral arterial disease detection methods, treatments to reduce the “systemic” risk of heart attack and stroke, as well as new claudication treatments. He is a principal investigator for the design and performance of single-site and multi-center clinical trials to evaluate the efficacy of medical treatments for vascular disorders. He is the chair of the PARTNERS database; serves on the USA steering committee and international publications committee of the REACH Registry; and is chair of the NHLBI-sponsored CLEVER trial that is evaluating the benefit, risk and health economics of supervised exercise vs. endovascular vs. optimal medical therapies for individuals with PAD and claudication.'Dr. Hirsch has provided leadership to a wide array of professional healthcare associations. He has served as founding member and Past-President of the Society for Vascular Medicine; is a Fellow of the American Heart Association (AHA) Council on Epidemiology and Prevention, and serves on the Steering Committee of the Interdisciplinary Working Group on Atherosclerotic Peripheral Vascular Disease. He has chaired the intersocietal Writing Committee which has recently published the “ACC-AHA Guidelines for the Management of Patients with Peripheral Arterial Disease”, as he has created the new intersocietal “PAD Guideline Implementation Task Force” to best disseminate the guideline.' He has recently served as the founding chair of the interdisciplinary, not-for-profit, “Peripheral Arterial Disease Coalition” which has co-developed the new national “PAD Public Awareness Campaign” with the National Heart, Lung, and Blood Institute, that was launched in September, 2006.''